APYX (Apyx Medical) Total Stockholders Equity: $10.66 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APYX Apyx Medical Corp APYX
72 GF Score
Price $3.06
GF Value $2.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Apyx Medical Total Stockholders Equity?

Apyx Medical APYX +0.05% 72 Total Stockholders Equity is $10.66 Mil as of Jun. 2026. GuruFocus rates APYX with a GF Score™ of 72/100 and a GF Value™ of $2.21 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Apyx Medical's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $10.66 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Apyx Medical's Book Value per Share for the quarter that ended in Jun. 2026 was $0.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Apyx Medical's Debt-to-Equity for the quarter that ended in Jun. 2026 was 3.72.

Apyx Medical  (NAS:APYX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Apyx Medical's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(10.663-0)/42.116
=0.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Apyx Medical's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.472 + 39.158) / 10.663
=3.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apyx Medical Total Stockholders Equity Related Terms

Apyx Medical Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Apyx Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apyx Medical Total Stockholders Equity Chart

Apyx Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.70 37.58 26.70 14.21 14.54

Apyx Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.25 5.85 14.54 12.83 10.66
APYX
72GF Score
Apyx Medical Corp APYX
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $10.66 Mil mean?
Apyx Medical (APYX) has a Total Stockholders Equity of $10.66 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Apyx Medical and its competitors.
Is Apyx Medical's Total Stockholders Equity too high?
Apyx Medical's current Total Stockholders Equity is $10.66 Mil. Overall, Apyx Medical has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Apyx Medical's Total Stockholders Equity compare to INGN and QSI?
Apyx Medical's Total Stockholders Equity of $10.66 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Apyx Medical and its competitors. Apyx Medical's current Total Stockholders Equity is $10.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apyx Medical stock overvalued right now?
Based on GuruFocus' analysis, Apyx Medical (APYX) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.21, compared to a current price of $3.06 — trading 38.5% above its estimated fair value. The current Total Stockholders Equity is $10.66 Mil. Apyx Medical's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Apyx Medical (APYX), the current Total Stockholders Equity is $10.66 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apyx Medical (APYX) Overvalued in 2026?

Based on GuruFocus' analysis, Apyx Medical stock appears to be overvalued. The current stock price of $3.06 is trading 38.5% above its estimated GF Value™ of $2.21. GuruFocus considers Apyx Medical to be Significantly Overvalued.

Key valuation signals for APYX:

  • Total Stockholders Equity: $10.66 Mil
  • GF Value™: $2.21 vs. price of $3.06 (38.5% above fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the APYX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apyx Medical Business Description

Other Exchanges BOV:Germany
Address 5115 Ulmerton Road, Clearwater, FL, USA, 33760
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
72GF Score

Get the complete analysis for APYX

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.06
Price
$2.21
GF Value